Risk Factors for Development of Stroke in Patients With Continuous-Flow Left Ventricular Assist Device Support as Destination Therapy
The HeartMate 3 was associated with decreased stroke rates, but risk remained high for patients who developed postoperative AF. Further investigation into protective strategies and use of amiodarone to treat AF after continuous-flow LVAD implantation is needed.
Authors
- Gregory A. Ewald (ORCID: https://orcid.org/0000-0002-6213-5758)
- Kunal Deepak Kotkar (ORCID: https://orcid.org/0000-0001-5768-7542)
- Muhammad Masood (ORCID: https://orcid.org/0000-0002-4627-1784)
- Nadia H. Bakir (ORCID: https://orcid.org/0000-0002-9909-8786)
- Akinobu Itoh (ORCID: https://orcid.org/0000-0002-3049-3411)
- Meghan O. Kelly (ORCID: https://orcid.org/0000-0003-3095-9848)
- Marc R. Moon (ORCID: https://orcid.org/0000-0002-4473-6867)
- Joel D. Schilling (ORCID: https://orcid.org/0000-0002-3884-1994)
- I Florea (ORCID: https://orcid.org/0000-0002-9474-3336)
- Ralph J. Damiano (ORCID: https://orcid.org/0000-0002-6361-6107)
- Spencer J. Melby
Institutions
- Barnes-Jewish Hospital (US)
- Jewish Hospital (US)
Publication Details
- Journal
- Texas Heart Institute Journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.14503/thij-23-8332
- Citations
- 1
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.67